Investors convinced the executives of Synergen that they needed to evaluate IL-1Ra for a disease with a more rapid outcome. RA studies were too slow to yield a quick profit. Thus, they picked sepsis syndrome.
Antiphospholipid Antibody Testing Update
Successes, challenges, and controversies of diagnostic methods for APS
New Year, New Faces
The Rheumatologist welcomes new editorial team
ACR Honors Contributions to Rheumatology
Rheumatologists recognized for their work in the field
Data-Driven, Optimal Patient Care and Clinical Research
Expanded opportunities to advance rheumatology will be offered by ACR’s ongoing registry efforts
A Short History of Rheumatoid Arthritis Therapeutics
Or, why I chose to become a rheumatologist
Health Policy Outlook for 2012
What’s in Store for Rheumatology in 2012?
Incoming ACR Volunteers
Karen Kolba, MD and Robert A. Colbert, MD, PhD
Incoming ARHP Volunteers
Laurie Hughell, PA- C, MPH and Susan Richmond, MS, PA-C
Chronic Osteoarthritic Pain Causes Brain Changes
Theory of condition-specific ‘brain signature’ sparks controversy
- « Previous Page
- 1
- …
- 94
- 95
- 96
- 97
- 98
- …
- 123
- Next Page »